×
For best experience we recommend to activate Javascript in your browser.
Recombinant ILDR2 (Bapotulimab Biosimilar) antibody
This Human Monoclonal antibody specifically detects ILDR2 (Bapotulimab Biosimilar) in FACS, BLI, ELISA, Func and SPR. It exhibits reactivity toward Human.
Quick Overview for Recombinant ILDR2 (Bapotulimab Biosimilar) antibody (ABIN7581531)
Target
ILDR2 (Bapotulimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for ILDR2 (Bapotulimab Biosimilar) antibodies
Human
Clonality
All clonalities for ILDR2 (Bapotulimab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for ILDR2 (Bapotulimab Biosimilar) antibodies
This ILDR2 (Bapotulimab Biosimilar) antibody is un-conjugated
Application
Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), ELISA, Functional Studies (Func), Surface Plasmon Resonance (SPR)
Product Details anti-ILDR2 (Bapotulimab Biosimilar) Antibody
(hide)
Expression System
CHO Cells
Purpose
Anti-ILDR2 Reference Antibody (bapotulimab)
Characteristics
Anti-ILDR2 Reference Antibody (bapotulimab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
Purity
>95 %
Isotype
IgG2SA
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Lyophilized
Concentration
1 mg/mL
Buffer
25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
Storage
4 °C,-80 °C
Storage Comment
+4°C,-80°C
Target Details for ILDR2 (Bapotulimab Biosimilar)
(hide)
Target
ILDR2 (Bapotulimab Biosimilar)
Target Type
Biosimilar
Molecular Weight
145.5 kDa
UniProt
Q71H61
Recently viewed
(hide)
Chat with us , powered by LiveChat